MDGL
Madrigal Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +12.5% ·
aandelenstroom -1.5% ·
netto nieuwe posities +11.1%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 123 | +1 | 10.48M | $5.62B | +9 | −7 |
| Q1 2026 | 124 | +7 | 12.07M | $6.32B | +9 | −3 |
| Q4 2025 | 116 | 0 | 12.47M | $7.26B | +1 | — |
| Q3 2025 | 19 | +1 | 6.80M | $3.12B | +1 | −1 |
| Q2 2025 | 16 | 0 | 6.45M | $1.95B | — | — |
| Q1 2025 | 13 | +1 | 2.28M | $753.61M | +1 | — |
| Q4 2024 | 12 | +2 | 2.15M | $662.73M | +2 | — |
| Q3 2024 | 9 | +1 | 1.41M | $299.66M | +3 | −2 |
| Q2 2024 | 8 | — | 1.43M | $401.79M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 733.70K | -14.6% | $155.71M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 733.70K | -14.6% | $155.71M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 405.65K | +1.4% | $86.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 405.65K | +1.4% | $86.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Marshall Wace ✦ | 80.40K | +4629.5% | $17.06M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Norges Bank ✦ (passief) | 69.97K | -39.7% | $14.85M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 54.65K | +388.4% | $11.60M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 54.65K | +388.4% | $11.60M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 44.50K | Nieuw | $9.44M | 0.0% | New | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 9.03K | Nieuw | $1.92M | 0.0% | New | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 9.03K | Nieuw | $1.92M | 0.0% | New | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 9.03K | Nieuw | $1.92M | 0.0% | New | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 9.03K | Nieuw | $1.92M | 0.0% | New | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 8.93K | Nieuw | $1.90M | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 5.12K | +11.0% | $1.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 5.12K | +11.0% | $1.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 5.12K | +11.0% | $1.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $9.44M | 0.0% |
| Wellington Management | $1.92M | 0.0% |
| Wellington Management | $1.92M | 0.0% |
| Wellington Management | $1.92M | 0.0% |
| Wellington Management | $1.92M | 0.0% |
| Millennium Management | $1.90M | 0.0% |
Verlaten
| Point72 Asset Management | $11.47M | was 0.0% |
| D. E. Shaw & Co. | $265,312 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 374 houders, 23.71M aandelen, $12.08B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 664 aand · $341,940
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie